Below are the financial statements of Teva Pharmaceutical Industries, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of USD | 2024 as of 2024-12-31 | 2023 as of 2023-12-31 |
|---|---|---|
| Assets | — | — |
| Current assets | — | — |
| Cash and cash equivalents | 3,300a | 3,226a |
| Accounts receivables, net of allowance for credit losses | 3,059a | 3,408a |
| Inventories | 3,007a | 4,021a |
| Prepaid expenses | 1,006a | 1,255a |
| Other current assets | 409a | 504a |
| Assets held for sale | 1,771a | 70a |
| Total current assets | 12,552a | 12,485a |
| Deferred income taxes | 1,799a | 1,812a |
| Other non-current assets | 462a | 470a |
| Property, plant and equipment, net | 4,581a | 5,750a |
| Operating lease right-of-use assets | 367a | 397a |
| Identifiable intangible assets, net | 4,418a | 5,387a |
| Goodwill | 15,147a | 17,177a |
| Total assets | 39,326a | 43,479a |
| Liabilities and equity | — | — |
| Current liabilities | — | — |
| Short-term debt | 1,781a | 1,672a |
| Sales reserves and allowances | 3,678a | 3,535a |
| Accounts payables | 2,203a | 2,602a |
| Employee-related obligations | 624a | 611a |
| Accrued expenses | 2,792a | 2,771a |
| Other current liabilities | 1,020a | 1,044a |
| Liabilities held for sale | 698a | 13a |
| Total current liabilities | 12,796a | 12,247a |
| Long-term liabilities | — | — |
| Deferred income taxes | 483a | 606a |
| Other taxes and long-term liabilities | 4,028a | 4,019a |
| Senior notes and loans | 16,002a | 18,161a |
| Operating lease liabilities | 296a | 320a |
| Total long-term liabilities | 20,809a | 23,106a |
| Total liabilities | 33,606a | 35,353a |
| Redeemable non-controlling interests | 340a | 0a |
| Equity | — | — |
| Teva shareholders’ equity | — | — |
| Ordinary shares of NIS 0.10 par value per share | 58a | 57a |
| Additional paid-in capital | 27,764a | 27,807a |
| Accumulated deficit | -15,173a | -13,534a |
| Accumulated other comprehensive loss | -3,148a | -2,697a |
| Treasury shares | -4,128a | -4,128a |
| Non-controlling interests | 7a | 620a |
| Total equity | 5,380a | 8,126a |
| Total liabilities, redeemable non-controlling interests and equity | 39,326a | 43,479a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Teva Pharmaceutical Industries’s data sources below and access millions more through our Disclosure Search.